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A B S T R A C T   
Primary cultures of cerebellar granule neurons (CGNs) derived from chicken embryos were used to explore the 
effects on developmental neurotoxicity by a complex defined mixture of persistent organic pollutants (POPs). Its 
chemical composition and concentrations were based on blood levels in the Norwegian/Scandinavian popula-
tion. Perfluorooctane sulfonic acid (PFOS) alone, its most abundant compound was also evaluated. Different 
stages of CGNs maturation, between day in vitro (DIV) 1, 3, and 5 were exposed to the POP mixture, or PFOS 
alone. Their combination with glutamate, an excitatory endogenous neurotransmitter important in neuro-
development, also known to cause excitotoxicity was evaluated. Outcomes with the mixture at 500x blood levels 
were compared to PFOS at its corresponding concentration of 20 μM. The POP mixture reduced tetrazolium salt 
(MTT) conversion at earlier stages of maturation, compared to PFOS alone. Glutamate-induced excitotoxicity was 
enhanced above the level of that induced by glutamate alone, especially in mature CGNs at DIV5. Glutathione 
(GSH) concentrations seemed to set the level of sensitivity for the toxic insults from exposures to the pollutants. 
The role of N-methyl-D-aspartate receptor (NMDA-R) mediated calcium influx in pollutant exposures was 
investigated using the non-competitive and competitive receptor antagonists MK-801 and CGP 39551. Obser-
vations indicate a calcium-independent, but still NMDA-R dependent mechanism in the absence of glutamate, 
and a calcium- and NMDA-R dependent one in the presence of glutamate. The outcomes for the POP mixture 
cannot be explained by PFOS alone, indicating that other chemicals in the mixture contribute its overall effect.   
1. Introduction 
Exposures in humans to complex mixtures of contaminants are sus-
pected to cause adverse health outcomes. Increased prevalence of neu-
rodevelopmental disorders, such as autism, attention-deficit 
hyperactivity disorder (ADHD), dyslexia, and other cognitive impair-
ments have been linked with exposure to environmental pollutants [1]. 
Pregnancy and early life stages are particularly vulnerable for exposure 
to toxicants, including persistent organic pollutants (POPs) [2]. POPs 
are mostly halogenated compounds that are highly resistant to envi-
ronmental degradation, and that bioaccumulate and biomagnify in 
living organisms [3]. Several POPs, including polychlorinated biphenyls 
(PCBs), organochlorine pesticides (OCPs), polybrominated diphenyl 
ethers (PBDEs), perfluorooctane sulfonic acid (PFOS), and 
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perfluorooctanoic acid (PFOA) are supposed to be developmental neu-
rotoxicants [1,4–6]. 
Human populations are exposed to a complex mixture of contami-
nants, which could have additive, synergistic or antagonistic effects. 
Experimental studies carried out in vitro and in vivo with mixtures 
showed that low-level exposure to chemicals that are not toxic on an 
individual basis can together lead to a biological or toxic effect if present 
in a mixture [7]. This kind of low-dose cocktail or mixture effects are of 
real concern to humans. Chemicals affecting similar adverse outcomes 
often act additively when present together in mixtures [8]. Chemical 
mixtures have often been defined by the modes of action of individual 
components and three basic types of action have been identified, 
namely: (I) similar action (dose or concentration addition): applied to 
mixtures in which the chemicals present have a similar mecha-
nism/mode of action and may differ in their potencies (i.e. the impact of 
similar concentrations/doses will differ). In this case the effects of the 
mixture can be estimated directly from sum of the doses/concentrations, 
scaled for relative toxicity/potency of the individual substances. (II) 
Dissimilar action (independent action): applied to chemicals with dis-
similar modes of action. In this case the action of mixture components 
can be calculated from the response of individual components (response 
addition) or the sum of biological responses (effects addition). (III) In-
teractions (synergism and antagonism): applied if the combined effect of 
two or more chemicals is either stronger (synergistic, potentiating, 
supra-additive) or weaker (antagonistic, inhibitive, sub-additive, 
infra-additive) than would be expected on the basis of dose/concentra-
tion addition or response addition. In this case the extent of interactions 
may vary according to the relative dose levels (e.g. too low to have such 
an effect); route of exposure (e.g. absorption too low or different meta-
bolism); duration of exposure (including bio-persistence of compo-
nents); and biological target [9–11]. 
Studies have shown that there is exposure to POPs in humans as wells 
in animals. In a Norwegian birth cohort study, concentrations of 27 POPs 
were reported in breast milk, reflecting the child’s early-life exposures, 
and certain POPs were associated with a neurodevelopmental disorder 
[12]. Flores-Ramírez et al. [13] showed the levels of multiple POPs in 
serum samples from children living in high-risk areas in Mexico, indi-
cating that the evaluation of the health risks posed to children living in 
contaminated areas is a high priority health issue. In another study, 
González-Mille et al. [14] reported the genotoxic effects in resident wild 
species exposed to complex mixture of POPs in the delta of the Coat-
zacoalcos river, Mexico. In the present study, we used a defined POP 
mixture designed by our group at the Norwegian University of Life 
Sciences (NMBU), Oslo. The concentration of the individual compounds 
was based on their respective levels in human blood in the Norwe-
gian/Scandinavian population [15]. PFOS is the compound with the 
highest concentration present in the total POP mixture and a potent 
developmental neurotoxicant. In a multi-pollutant analysis of 27 POPs 
in a Norwegian birth cohort study, early-life exposure to β-hexa-
chlorocyclohexane (HCH) and PFOS was associated with increased risk 
of ADHD [12]. Recently, European population-based studies including 
Human Milk Study (HUMIS; Norway) suggested that there may be an 
increased prevalence of ADHD in girls, in children from nulliparous 
women, and in children from low-educated mother in association with 
PFOS and PFOA exposure [16]. Also, our PFOS concentration is com-
parable to reported concentrations of 20 μM (lowest observed effect 
concentration) and 38 μM (lethal concentration killing 50 % of the cells) 
using tetrazolium salt (MTT) assay in rat CGNs [17], and all other 
component in the mixture had a concentration lower than its effective 
dose range. We have previously examined the toxicity of each individual 
PFAAs compounds in the POP mixture in cultured rat CGNs [18]. We 
observed that the two sulfonated-induced, but not perfluoroalkyl car-
boxylic acid-induced toxicity was associated with N-methyl-D-aspartate 
receptor (NMDA-R) and PFOS was the most effective on NMDA-R [18]. 
This receptor plays an important role in cerebellar development [19]. 
Here it should be pointed out that in the present study we used PFOS as a 
single compound with a concentration, which overlaps the concentra-
tion of the POP mixture 
In addition to its role in motor control and coordination, the cere-
bellum is involved in learning and memory, language, executive func-
tioning, as well as diseases such as ADHD, autism spectrum disorders, 
and schizophrenia [20]. The embryonic chicken cerebellum can be used 
as a model, since it shows developmental stages similar to those in 
humans [19]. Cerebellar granule neurons (CGNs) form the largest ho-
mogeneous neuronal population in the mammalian brain, and are the 
main excitatory neurons of the cerebellar cortical circuitry [21]. The 
comparative anatomy studies have shown that the cerebellum is a 
well-conserved structure between species [22]. The migration of granule 
neurons through layers of the cerebellar cortex from the external 
granule layer to the internal granule layer is a key feature for the 
development of cerebellum. This occurs prenatally before hatching in 
chicken and to a large extent postnatally in some mammals, including 
humans [19]. The migration of neurons in a developing brain is guided 
through N-methyl-D- aspartate receptors (NMDA-R) mediated Ca2+
influx, among other signals [23]. Alterations in migration could be 
indicative of impaired neurodevelopment [19]. CGNs isolated at em-
bryonic day (ED) 17–18 from chicken is comparable to postnatal day 7–8 
in the rat [24]. In addition, cultured chicken CGNs develops 
NMDA-mediated toxicity more rapidly than cultured rat CGNs and 
respond similarly to glutamate excitotoxicity with ROS production and 
activation of caspase-3 [24]. CGNs derived from chicken cerebellum 
serve to study brain development after exposure to different pharma-
ceuticals, drugs [25–28] and environmental toxins [29]. This is an 
advantage when considering chicken embryo CGNs as a model for 
NMDA receptor development and thus makes the cerebellum a potential 
target organ for developmental toxicity (DNT) induced by POPs. 
Glutamate is a major excitatory neurotransmitter in the vertebrate 
central nervous system (CNS) and under normal circumstances con-
tributes to neural transmission, development, differentiation and plas-
ticity. However, under pathological stimuli excessive glutamate release 
leads to overactivation of glutamate receptors, resulting in an 
augmented intracellular Ca2+-influx [30]. This can lead to excitotox-
icity, resulting in neuronal death [31,32]. Excitotoxicity is involved in 
many neurodegenerative diseases such as Huntington’s disease, Alz-
heimer’s disease, lateral amyotrophic sclerosis, Parkinson’s disease, 
stroke, or traumatic brain injury [30]. Among different types of gluta-
mate receptors, the N-methyl-D-aspartate receptor (NMDA-R) plays an 
important role in mediating neuronal death observed in most primary 
cultured neurons [33]. In CGNs intracellular glutathione (GSH) plays a 
major role in protecting cells against injury caused by reactive oxygen 
species (ROS) following excitotoxic insults [34]. A reduction in GSH 
level can lead to glutamate-induced cell death [35]. Calcium influx plays 
a critical role in glutamate-induced neurotoxicity [32]. NMDA-R chan-
nels are highly Ca2+-permeable and function as heterotetrameric as-
semblies that typically consist of GluN1 and GluN2 subunits, or GluN2 
and GluN3 subunits. The subunit composition of NMDA-Rs changes 
during development in response to neuronal activity or sensory experi-
ences [36]. Also, in vitro the expression of the NMDA-R subunits changes 
with time and maturation of CGNs [37]. Because of this previously re-
ported time-dependent changes in NMDA-R subunits expression, we 
conducted the present study at different stages of maturation at day in 
vitro (DIV) 1, 3 and 5. We assume that neuronal cells exposed at DIV5 to 
express more mature and more sensitive neurons than cells exposed at 
DIV1 or 3. 
A role of NMDA-R in the excitotoxity after exposure to same POP 
mixture, and PFOS have been shown in rat CGNs as well in chicken CGNs 
[18,38].The possible involvement of NMDA-Rs in excitotoxicity may be 
explored by using NMDA-R inhibitors. MK-801 is a non-competitive 
NMDA-R open channel blocker and binding sites are situated within 
the ion channel [39,40]. CGP-39551 is a competitive antagonist that 
binds to the glutamate binding site of the receptor [41]. 
The hypothesis of the present work was that a complex human 
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relevant POP mixture with defined chemical composition and concen-
trations could affect NMDA-R signaling and downstream calcium influx, 
glutathione level, and excitotoxicity, and that the mixture would share 
some mechanisms with PFOS, a main component of the mixture. 
2. Materials and methods 
2.1. Chemicals and PFOS, and POP mixture 
Basal Eagle’s medium (BME) and L-glutamine were purchased from 
Lonza BioWhittaker (Verviers, Belgium). Penicillin-streptomycin and 
chicken serum were acquired from Gibco, Life Technologies (Paisley, 
UK). Dimethyl sulfoxide (DMSO), monochlorobimane (mBCl), cytosine 
β-D-arabinofuranoside (Ara-C), MK-801, Poly-L-lysine and thiazolyl blue 
tetrazolium bromide (MTT) powder were all obtained from Sigma- 
Aldrich (St. Louis, US). Fura-2 AM and Hoechst 33342 were purchased 
from Invitrogen™ Molecular Probes (Eugene, US). CGP 39551 was from 
Novartis (Basel, Switzerland). Perfluorooctanesulfonic acid potassium 
salt (PFOS ≥ 98 %) was purchased from Sigma-Aldrich (St. Louis, MO 
USA). All other reagents were standard laboratory grade. 
The defined POP mixture was designed and prepared by our group at 
the Norwegian University of Life Sciences (NMBU), Oslo (Norway), 
detailed in [15]. It contains 29 different compounds: six perfluorinated 
compounds, seven brominated compounds, and 16 chlorinated com-
pounds (Table 1). The concentrations of the chemicals in the mixture 
were based on Scandinavian human blood levels. The stocks used in the 
present study had a concentration of 106 times human blood levels and 
stocks were created using DMSO as a solvent. Working stocks were 
prepared by creating suitable dilutions in DMSO in glass vials at con-
centrations 1000 times higher than the final exposure concentrations in 
the medium of 500x, where x indicates ‘times human blood concentra-
tions’. Vials were stored in − 80 ◦C. For MTT conversion and glutathione 
measurements cells in the culture were exposed to test compounds for 
24 h and for intracellular calcium measurements for 90 min. 
Table 1 
The total in vitro mixture containing 29 different POPs based on human blood levels, detailed in [15].  
Compound Average human blood levels a 
ng/g lipid 
Average human blood levels b 
ng/mL 
Total mixture stock nominal concentration 
c mg/mL 
Total mixture stock Measured 
concentration d μM 
PCBs     
PCB 28 2.13 0.013 0.013 31.1 
PCB 52 1.6 0.01 0.01 20.5 
PCB 101 1.3 0.008 0.008 24.5 
PCB 118 10.67 0.064 0.064 137.9 
PCB 138 37 0.222 0.222 429.5 
PCB 153 60.33 0.362 0.362 698.3 
PCB 180 32.33 0.194 0.194 339 
∑ PCBs 145.36 0.873 0.873 1680.8  
OCPs 
p,p’-DDE 83.67 0.502 0.502 1065.9 
HCB 19.5 0.117 0.117 228.2 
α-Chlordane 1.8 0.011 0.011 23.7 
Oxychlordane 3.7 0.022 0.022 33 
trans- 
Nonachlor 
6.8 0.041 0.041 99.1 
α-HCH 1 0.006 0.006 16.8 
β-HCH 8.77 0.053 0.053 75.6 
γ-HCH 1 0.006 0.006 16.8 
Dieldrin 4 0.024 0.024 56.2 
∑ OCPs 130.24 0.782 0.782 1615.3 
∑ PCBs þOCPs 275.6 1.655 1.655 3296.1  
BFRs 
PBDE 47 1.43 0.009 0.009 17.8 
PBDE 99 0.59 0.004 0.004 7.5 
PBDE 100 0.36 0.002 0.002 3.8 
PBDE 153 1.64 0.01 0.001* 2.1 
PBDE 154 0.29 0.002 0.002 3 
PBDE 209 1.81 0.011 0.011 9.4 
HBCD 4.1 0.025 0.025 54.5 
∑ BFRs 10.22 0.063 0.053 98.1  
PFAAs 
PFHxS N/A 3.45 3.45 7809.2 
PFOS N/A 29.425 29.425 41522.1 
PFOA N/A 4.523 4.523 4209.4 
PFNA N/A 0.8 0.8 1092.5 
PFDA N/A 0.495 0.495 375.4 
PFUnDA N/A 0.56 0.56 336.8 
∑ PFAAs N/A 39.253 39.253 55345.4 
N/A - Not applicable. 
Abbreviations: PCBs (polychlorinated biphenyls); OCPs (organochlorine pesticides); BFRs (brominated flame retardants); PFAAs (perfluoroalkyl acids). 
a Average human blood levels of POPs based on a literature review of Scandinavian values, providing the basis for the in vitro mixture. 
b Average human blood levels of POPs converted to ng/mL. A fat percentage of 0.6 % was used. 1 mL blood was considered to have a weight of 1 g. 
c Nominal concentration of the various compounds in the total mixture stock – 1000000x the average concentration in blood. 
d Measured concentrations of the various compounds in the total mixture stock converted to μM. 
* The nominal concentration of PBDE 153 included in the total mixture stock was ten times lower than originally intended. 
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2.2. Chicken egg incubation and isolation of cerebellar granule neurons 
(CGNs) 
Eggs (Gallus gallus, weight 50− 60 g) were obtained from Nortura 
Samvirkekylling (Våler, Norway) and incubated at 37.5 ◦C in 45 % 
relative humidity in an OvaEasy 380 Advance EXII Incubator (Brinsea, 
Weston-super-Mare, UK). In accordance with the 3R principles, the 
mother is excluded from the experiments and the number of fertilized 
eggs is easy to control. The viability of the embryos was checked with 
trans-illumination using a LED lamp (Brinsea) by observing spontaneous 
movement. Cultures of cerebellar granule neurons (CGNs) were pre-
pared on Embryonic Day (ED) 17. The embryos in ovo were anaes-
thetized for 7 min by hypothermia in crushed ice, prior to decapitation. 
Animals were handled in accordance with the Norwegian Animal Wel-
fare Act and the EU directive 2010/63/EU. The granule neurons were 
isolated as previously described [42]. Cells for each isolation were ob-
tained from the pooled cerebella of 15–18 chicken embryos and diluted 
to a centration of 1.8 × 106 cells/mL. From each isolation, 4–6 replicates 
(sister wells) were prepared per exposure. Each isolation was considered 
as one independent experiment. In total of 3− 4 independent experi-
ments from separate cell isolates were performed. After isolation, cells 
were seeded onto poly-L-lysine-coated (0.01 mg/mL) dishes (diameter 
35 mm) or 96 well plates in BME supplemented with chicken serum (7.5 
%), KCl (25 mM), L-glutamine (2 mM), insulin (100 nM) and 
penicillin-streptomycin (1%) at 37 ◦C and 5% CO2 for 24 h. Then the 
medium was replaced with serum-free BME as described previously [29] 
supplemented with Ara-C (10 μM) to prevent growth of non-neuronal 
cells. Cultures contained about 70–80 % neurons. The neurons were 
exposed with the test compounds on day in vitro (DIV) 1, 3 and 5, and 
then left undisturbed in an incubator until further analysis. For all the 
assays cells were seeded on the same day DIV0 (day of platting). MTT 
DIV1 experiment was performed only to find the cytotoxic 
concentration-range for the POP mixture and PFOS. Based on this a 
concentration of 500x human blood levels for POP mixture and the 
corresponding concentration of 20 μM PFOS was used for further 
mechanistic studies on DIV3 and DIV5. 
2.3. Quantification of cell viability by tetrazolium MTT conversion assay 
The MTT assay procedure has been described previously [18]. It is 
based on the conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT), a pale yellow substrate to a dark blue for-
mazan product by the mitochondrial enzyme succinate dehydrogenase 
in living cells [43]. MTT was prepared freshly as a stock solution of 
5 mg/mL in PBS. DIV1, 3 or 5 cultures were exposed for a further 24 h 
with the test compounds after which 10 μl MTT stock solution was added 
to each well of the 96 well plate and subsequently incubated at 37 ◦C for 
3− 4 h. Afterwards, the MTT-solution was replaced with 100 μl 
DMSO/well for dissolution of the formazan salt and after 30 min 
absorbance was measured at 570 nm in a CLARIOstar® microplate 
reader (BMG Labtech, Ortenberg, BW, Germany). The average of back-
ground value from wells containing cells without MTT, was subtracted 
from the final optical density. Cell viability was measured as a per-
centage absorbance of the sample compared with the absorbance of the 
solvent control. 
2.4. Glutathione measurements using monochlorobimane (mBCl) 
fluorescent probe 
Total reduced glutathione (GSH) levels in CGNs were measured with 
monochlorobimane (mBCl) as described previously [44]. mBCl is a 
non-fluorescent probe and forms a stable fluorescent conjugate with 
GSH in a reaction catalyzed by the GSH S-transferases [45]. In brief, cells 
were seeded in black 96 wells plates and were exposed at DIV3 or DIV5 
with the test compounds for 24 h. Then medium was removed and 
replaced with new medium containing 40 μM of mBCl and incubated 
further in the dark at 37 ◦C for 30 min. Subsequently the medium was 
removed. Plates were washed with freshly prepared experimental buffer 
containing 140 mM NaCl, 3.5 mM KCl, 15 mM Tris HCl (pH 7.4), 5 mM 
glucose, 1.2 mM Na2HPO4 (pH 7.4), and 2 mM CaCl2. Hundred μl of the 
buffer was added to each well, and mBCl fluorescence was measured at 
excitation wavelength of 380 nm (15 nm bandwidth) and emission 
wavelength of 478 nm (21 nm bandwidth) using a CLARIOstar® plate 
reader. Further, in the same exposure, we also quantified cell number 
using nuclei staining with Hoechst 33342. Buffers were replaced with 
Hoechst 33342 (0.4 μg/mL) and incubated in dark for 1 min. Subse-
quently, the plate was read at excitation wavelengths of 350 nm (22 nm 
bandwidth) and emission wavelengths of 461 nm (36 nm bandwidths). 
This measurement was used to correct for cell number in the calculations 
for GSH levels after subtraction of blank values. 
Fig. 1. Assessment of cytotoxicity in CGNs at DIV1 (A) or DIV3 (B) or DIV5 (C) using the tetrazolium MTT conversion assay. CGNs were exposed for 24 h to solvent 
control (SC, 0.1 % DMSO), glutamate (Glu), 100 μM (together with 10 μM glycine as co-agonist), PFOS (in μM) or POP mixture (x fold human blood levels), alone or 
in the presence of glutamate. All values were presented relative to the SC (defined as 100 %). Data are mean ± SD, n = 3 to 4 independent experiments (from separate 
cell isolates), each with replicates >4 per group/exposure, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 one-way ANOVA followed by Dunnett’s multiple 
comparisons test, #p < 0.05, ####p < 0.0001 unpaired t-test. 
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2.5. Measurement of intracellular calcium concentrations using Fura-2 
AM 
The procedure has been described previously [44], with minor 
modifications. In brief, CGNs were seeded in CELLBIND® 96-Well 
Microplates, Corning® (Corning Incorporated, Kennebunk, ME, US). 
On DIV3 or DIV5 cells were loaded with the membrane permeable 
Ca2+-binding fluorescent probe Fura-2 AM (5.2 μM) in medium and 
incubated at 37 ◦C for 40 min. Then the medium was replaced with 
experimental buffer supplemented with 1 mM MgSO4 (wash buffer) for 
de-esterification. After 15 min of incubation baseline [Ca2+]i value was 
measured at excitation wavelengths 340 nm and 380 nm (12 nm band-
widths) and emission at 510 nm (30 nm bandwidths) using orbital 
averaging. Subsequently, wash buffer was replaced with test compounds 
in experimental buffer and [Ca2+]i value was measured 90 min post 
treatment. For calculation, the average [Ca2+]i value obtained at 90 min 
after treatment was expressed relative to the average [Ca2+]i value ob-
tained prior to treatment (baseline value) at time point 0 (set to 1). 
Average of background autofluorescence from wells containing cells 
without Fura-2 AM were subtracted from excitations at 340 nm and 
380 nm before the 340/380 ratio was calculated. 
2.6. Statistical analysis 
Results are presented as mean ± standard deviation (SD) from n = 3 
to 4 independent experiments (from separate cell isolates), each with 
replicates >4 per group/exposure. So, the total sample size for the 
calculation of SD was 12–16 replicates. Data was analyzed using 
Microsoft Excel in addition to Graph pad 8.2 (San Diego, CA). Outlier 
values were tested for by the built-in feature in GraphPad (Robust 
regression and Outlier removal, Q = 1%). A one-way analysis of variance 
(ANOVA) followed by Dunnett’s multiple comparison test was used to 
determine significant differences between treatments and the corre-
sponding control. An unpaired t-test was used for comparison when 
appropriate between two groups. A p-value of < 0.05 was considered 
significant. 
3. Results 
3.1. Effects of POP mixture or PFOS on viability in CGNs 
To explore the influence of CGNs maturation on exposure outcomes, 
CGNs at DIV1, DIV3, and DIV5 were used. Cell viability was evaluated 
by mitochondrial activity as measured by MTT (Fig. 1A-C). On DIV1, in 
the absence of glutamate a significant reduction in MTT was seen only at 
500x by 29 % (P < 0.01) as compared to solvent control. At DIV1, PFOS 
only reduced MTT activity by 91 % (P < 0.0001) at 100 μM. Concen-
trations of PFOS in the 20 μM range did not show significant loss of MTT 
activity before DIV5. Therefore, a concentration of 500x was used for the 
POP mixture and the corresponding concentration of 20 μM PFOS was 
used in further studies. In the presence of glutamate, the effect of PFOS 
already became significant with a reduction of 33 % (P < 0.0001) at 
DIV3 or by 25 % (P < 0.05) at DIV5, when compared to PFOS alone; and 
by 21 % (P < 0.001) at DIV3 or by 30 % (P < 0.05) at DIV5 as compared 
to glutamate (Fig. 1B, C). For the POP mixture MTT activity was 
significantly reduced by 28 % (P < 0.0001) at DIV3, and by 35 % 
(P < 0.0001) at DIV5, when compared to solvent control (Fig. 1B, C). 
Again, in the presence of glutamate this reduction was more pronounced 
(Fig. 1B, C). In the presence of glutamate, the POP mixture led to a 
further significant reduction by 36 % (P < 0.0001) at DIV3 or by 41 % 
(P < 0.0001) at DIV5, when compared to POP mixture alone; and by 43 
% (P < 0.0001) at DIV3 or by 42 % (P < 0.001) at DIV5, when compared 
to glutamate. 
3.2. Effects of POP mixture or PFOS on the depletion of intracellular 
glutathione levels in CGNs 
Intracellular levels of glutathione determine the sensitivity of CGNs 
against chemical induced cytotoxicity. Thus, we tested if the exposures 
resulted in depletion of the glutathione levels (Fig. 2A, B). Glutamate led 
to a decrease in glutathione level on both DIV3 and DIV5 by 42 % 
(P < 0.05 significantly) and by 29 % (P < 0.09 non-significantly), 
respectively as compared to solvent control. PFOS led to decrease in 
glutathione levels which were more pronounced on DIV5 and caused a 
significant reduction by 52 % (P < 0.01), when compared to solvent 
control. Similarly, the POP mixture resulted in decreased levels of 
glutathione on both days by 55 % (P < 0.001) at DIV3 and by 43 % 
(P < 0.01) at DIV5 as compared to solvent control. The combination 
with glutamate did not alter the effect compared to PFOS alone. How-
ever, when combined with the POP mixture a further reduction in 
intracellular glutathione levels by 18 % (non-significantly) at DIV3 or by 
32 % (P < 0.05) at DIV5 as compared to POP mixture was seen; and by 
36 % (non-significantly) at DIV3 or by 45 % (P < 0.001) at DV5, when 
compared to glutamate alone. 
Fig. 2. Assessment of glutathione levels in CGNs at 
DIV3 (A) or DIV5 (B) using mBCl assay. CGNs were 
exposed for 24 h to solvent control (SC, 0.1 % DMSO), 
glutamate (Glu) 100 μM (together with 10 μM glycine 
as co-agonist), PFOS 20 μM, or POP mixture (500x fold 
human blood levels), alone or in the presence of 
glutamate. All values were presented relative to the SC 
(defined as 1). Data are mean ± SD, n = 3 to 4 experi-
ments (from separate cell isolates), each with replicates 
>4 per group/exposure, *p < 0.05, **p < 0.01, 
***p < 0.001, one-way ANOVA following Dunnett’s 
multiple comparisons test, #p < 0.05 unpaired t-test.   
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3.3. Effects of POP mixture or PFOS on intracellular Ca2+ concentration 
in CGNs 
Since glutamate excitotoxicity raises intracellular calcium levels, we 
measured [Ca2+]i using the Fura-2 AM fluorescent probe following ex-
posures at DIV3 and 5 (Fig. 3A, B). As expected, glutamate alone induced 
a significant increase in [Ca2+]i by 89 % (P < 0.001) at DIV3 or by 122 % 
(P < 0.001) at DIV5, when compared to solvent control. In contrast, 
neither PFOS, nor the POP mixture alone were able to increase [Ca2+]i. 
However, in combination with glutamate they caused a further, signif-
icant increase in [Ca2+]i. PFOS in combination with glutamate caused a 
significant increase in [Ca2+]i by 185 % (P < 0.0001) at DIV3 or by 168 
% (P < 0.01) at DIV5, when compared to PFOS alone; and POP mixture 
by 232 % (P < 0.0001) at DIV3 or by 174 % (P < 0.01) at DIV5, when 
compared to POP mixture alone. 
3.4. Effects of POP mixture or PFOS on intracellular Ca2+ concentration 
in CGNs in combination with NMDA-R antagonists 
To examine whether the increases in [Ca2+]i seen in Fig. 3 could be 
the results of influx via the NMDA-R, we tested the effect of two NMDA-R 
antagonists, the non-competitive, open channel blocker MK-801 or the 
competitive antagonist CGP 39551 (Fig. 4A, B). 
Neither antagonists alone affected [Ca2+]i as compared to solvent 
control on any of the days. In the presence of MK-801, glutamate 
induced [Ca2+]i was significantly reversed to control levels on both days 
(P < 0.001 at DIV3 and P < 0.05 at DIV5). The reduction by CGP 39551 
was less efficient (non-significant). Interestingly, on both DIV3 and 5, 
MK-801 was capable of reversing the [Ca2+]i to control levels for both 
PFOS or the POP mixture combined effect with glutamate. At either of 
the days, CGP 39551 also reduced [Ca2+]i, induced by the combined 
effect of PFOS and glutamate, but not statistically significant. CGP 
39551 showed no inhibition effect on [Ca2+]i induced by the combined 
effect of POP mixture and glutamate. 
Fig. 3. Intracellular Ca2+ measurements in CGNs at 
DIV3 (A) or DIV5 (B) using Fura-2 AM assay. CGNs 
were exposed for 90 min to solvent control (SC, 0.1 % 
DMSO), glutamate (Glu) 100 μM (together with 10 μM 
glycine as co-agonist), PFOS 20 μM, or POP mixture 
(500x fold human blood levels), alone or in the pres-
ence of glutamate. Before exposure, baseline [Ca2+]i 
was measured at time 0. The baseline was set to 1. Cells 
were exposed to test compounds for 90 min. Measured 
[Ca2+]i were expressed relative to the baseline. Data 
are mean ± SD, n = 3 to 4 experiments (from separate 
cell isolates), each with replicates >4 per group/expo-
sure, **p < 0.01, ***p < 0.001, ****p < 0.0001 one- 
way ANOVA followed by Dunnett’s multiple compari-
sons test, ##p < 0.01, ####p < 0.0001 unpaired t- 
test.   
Fig. 4. Intracellular Ca2+ measurements in 
CGNs at DIV3 (A) or DIV5 (B) using Fura-2 AM 
assay. CGNs were exposed for 90 min to solvent 
control (SC, 0.1 % DMSO), glutamate (Glu) 100 
μM (together with 10 μM glycine as co-agonist), 
PFOS 20 μM, or POP mixture (500x fold human 
blood levels) alone or in the presence of gluta-
mate. Cells were treated in the presence and 
absence of the open NMDA-R channel blocker 
MK-801 (5 μM) or the competitive NMDA-R 
antagonist CGP 39551 (100 μM). Before expo-
sure, baseline [Ca2+]i were measured at time 0. 
The baseline was set to 1. Cells were exposed to 
test compounds for 90 min. Measured [Ca2+]i 
were expressed relative to the baseline. Data-
points for SC, Glu, PFOS 20 μM +Glu, and 
500x +Glu, are identical to Fig. 3. Data are 
mean ± SD, n = 3 to 4 experiments (from sepa-
rate cell isolates), each with replicates >4 per 
group/exposure, *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001 one-way ANOVA 
followed by Dunnett’s multiple comparisons 
test.   
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3.5. Neuroprotective effects of NMDA-R antagonists on reduced MTT 
activity in POP mixture or PFOS-induced toxicity 
We explored if the NMDA-R antagonists were also capable of 
rescuing cells from reduced MTT activity, alone or combined with 
glutamate. We observed the NMDA-R antagonists were still capable of 
rescuing the CGNs in situations where PFOS and the POP mixture 
reduced MTT activity (Fig. 1C), albeit in absence of Ca2+ influxes 
(Fig. 3). At DIV 5, MK-801 (P < 0.0001) proved more effective than CGP 
39551 (P < 0.05) in rescuing PFOS-induced toxicity. But both 
Fig. 5. Assessment of neuroprotective effects of 
NMDA-R antagonists in PFOS or POP mixture- 
induced cytotoxicity in the absence of gluta-
mate in CGNs at DIV3 (A) or DIV5 (B) using 
tetrazolium MTT conversion assay. CGNs were 
exposed for 24 h to solvent control (SC, 0.1 % 
DMSO), PFOS 20 μM or POP mixture (500x fold 
human blood levels). Cells were treated in the 
presence and absence of the open NMDA-R 
channel blocker MK-801 (5 μM) or the 
competitive NMDA-R antagonist CGP 39551 
(100 μM). Datapoints for SC, PFOS 20 μM, and 
500x, are identical to Fig. 1B and C. All values 
were presented relative to the SC (defined as 
100 %). Data are mean ± SD, n = 3 to 4 exper-
iments (from separate cell isolates), each with 
replicates >4 per group/exposure, *p < 0.05, 
***p < 0.001, ****p < 0.0001 one-way ANOVA 
followed by Dunnett’s multiple comparisons 
test.   
Fig. 6. Assessment of neuroprotective effects of 
NMDA-R antagonists in PFOS or POP mixture- 
induced cytotoxicity in the presence of gluta-
mate in CGNs at DIV3 (A) or DIV5 (B) using 
tetrazolium MTT conversion assay. CGNs were 
exposed for 24 h to solvent control (SC, 0.1 % 
DMSO), glutamate (Glu) 100 μM (together with 
10 μM glycine as co-agonist), PFOS 20 μM or 
POP mixture (500x fold human blood levels), 
alone or in the presence of glutamate. Cells 
were treated in the presence and absence of the 
open NMDA-R channel blocker MK-801 (5 μM) 
or the competitive NMDA-R antagonist CGP 
39551 (100 μM). CGNs were exposed to gluta-
mate. All values were presented relative to the 
SC (defined as 100 %). Datapoints for Glu, PFOS 
20 μM +Glu, and 500x + Glu are identical as in 
Fig. 1B and C. Data are mean ± SD, n = 3 to 4 
experiments (from separate cell isolates), each 
with replicates >4 per group/exposure, 
*p < 0.05, **p < 0.01, ***p < 0.00, 
****p < 0.0001 one-way ANOVA following 
Dunnett’s multiple comparisons test.   
Table 2 
The comparison between PFOS and the POP mixture exposure.   
Without Glutamate With Glutamate 
A) DIV3 PFOS 20 μM POP mixture 500x Difference between means ± SEM PFOS 20 μM POP mixture 500x Difference between means ± SEM 
MTT conversion 95.61 % 72.50 % 23.11 ± 5.095 **** 63.90 % 46.07 % 17.84 ± 3.183 **** 
Glutathione levels 0.7873 0.4504 − 0.3369 ± 0.1151 ** 0.7775 0.3676 − 0.4099 ± 0.09090 **** 
[Ca2+]i 1.984 2.030 − 0.04679 ± 0.3086 5.648 6.735 − 1.087 ± 0.3393 * 
B) DIV5       
MTT conversion 61.48 % 64.87 % − 3.395 ± 6.093 46.11% 38.35 % 7.760 ± 5.817 
Glutathione levels 0.4828 0.5692 0.08635 ± 0.08092 0.4690 0.3858 − 0.08320 ± 0.05387 
[Ca2+]i 2.105 2.236 − 0.1301 ± 0.4005 5.665 6.131 − 0.4660 ± 0.7437 
An unpaired t-test was performed for the comparison between PFOS and POP mixture, in the absence of glutamate or in the presence of glutamate. *P < 0.05, 
**P < 0.01, and ****P < 0.0001 considered significant. MTT conversion values were presented relative to the solvent control (defined as 100 %); glutathione levels 
relative to the solvent control (defined as 1); and [Ca2+]i relative to the baseline (before exposure, set to 1). A represents DIV3 and B DIV5. 
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antagonists (P < 0.0001) were equally effective at rescuing the POP 
mixture induced toxicity (Fig. 5B). 
In the presence of glutamate, Ca2+ influxes were reduced by NMDA- 
R blockers (Fig. 4). In this situation we found MK-801 was very effective 
in rescuing cells from reduction of MTT induced by either PFOS or POP 
mixture (Fig. 6A, B). CGP 39551 also restored MTT activity at either day, 
albeit in a less efficient manner (Fig. 6A, B). 
3.6. Comparison between POP mixture and PFOS at DIV 3 and 5, in 
absence or presence of glutamate 
Table 2 summarizes the direct comparison between the effect for the 
POP mixture 500x with the corresponding concentration of 20 μM PFOS, 
at two different stages of maturation (DIV 3 and 5). We observed sig-
nificant differences in MTT conversion (P < 0.0001 for both without and 
with glutamate) and glutathione levels (P < 0.01 without glutamate and 
P < 0.0001 with glutamate) between the exposure of POP mixture and 
PFOS at DIV3 either alone or in combination of glutamate. However, 
these differences disappeared at DIV5. Ca2+ influxes were at the same 
order of magnitude for each exposure at each day. 
4. Discussion 
Our work was aimed at investigating cellular mechanisms of POPs 
exposures, and the results showed that a POP mixture based on human 
blood levels from the Norwegian/Scandinavian population affects 
NMDA-R signaling in CGNs from chicken embryos at critical stages of 
cerebellar development. NMDA-R signaling is an important event in 
early development of cerebellum [19] and changes in the expression of 
this receptors have been linked to neurological disorders [46]. It is 
difficult to translate pure in vitro work into human hazard and risk 
assessment. Although we noticed effects at 500x blood levels, which 
might be considered a high concentration, it should be noted that the 
exposure to POPs is individualistic in nature and certain groups of 
people may have these levels of exposures for certain POPs similar to 
these concentrations (summarized in Supplementary Table 2). Our 
PCBs, chlordane, and PBDEs at 500x are comparable to reported levels 
in Inuit population [47]. DDE concentration in the 500x mixture is 
comparable to children in African regions with indoor residual spraying 
(IRS) of insecticides including DDT, which has reported levels of p, 
p′-DDE up to 19,772 ng/g lipid (118 ng/mL blood) and 33,605 ng/g 
lipid (201 ng/g blood), at 12 and 24 months of age, respectively [48]. 
Extremely high concentration of PFOS has been reported in Chinese 
factory workers [49], at levels about ten times higher than in our POP 
mixture at 500× . Most studies examining effects of POPs use single 
compounds, and often at high concentrations. However, in real life we 
are exposed simultaneously to a large number of chemicals, thus mixture 
studies at environmentally relevant concentrations are of great impor-
tance. When chemicals co-occur, they may act additively, displaying 
non-interaction, which is currently believed to be the most common 
scenario, especially at low concentrations [50,51]. Although less 
commonly observed, they may also display interactive synergistic (more 
than additive) or antagonistic (less than additive) effects. Furthermore, 
it should not be presumed that concentration lower than 500x can be 
considered safe, because of the fundamental role of the molecular target, 
namely NMDA-R signaling, in cerebellar development at critical stages 
of development. It should also be stressed that our in vitro exposures are 
of an acute short-term character, whereas real-life exposures start from 
conception onwards and are of a chronic nature. Measured concentra-
tions in adult human brain tissues, thereby reflecting long-term expo-
sure levels of PCBs or PBDEs have been reported as summarized in 
Supplementary Table 3. These levels were associated to neurological 
disorders [52,53].Together this raises concern about safe lower limits of 
exposure. Safe limits might potentially be lower for women during 
pregnancy and lactation in the work environment than for other groups. 
In addition, the information gained on molecular target and pathways is 
useful in the Adverse Outcome Pathway (AOP) framework, where it can 
add knowledge into existing AOPs for DNT [54] and/or form the basis of 
new AOPs. 
PFOS belongs to the chemical class of per- and polyfluoroalkyl sub-
stances (PFAS), a family of emerging persistent pollutants of increasing 
concern with regards to adverse health outcomes, including cognitive 
outcomes [55]. The POP mixture outcomes were compared with PFOS 
exposure. The concentration used for PFOS exposure was set to 20 μM, 
equivalent to its concentration in the POP mixture 500x exposure. 
We used MTT assay to quantify direct effect of the exposures on cell 
viability. Our observations indicated that CGNs sensitivity increases 
with maturation in culture. Exposure of the CGNs to the excitotoxin 
glutamate reduced the MTT activity significantly at DIV3, with 
increased sensitivity at DIV5. The increase in sensitivity at different 
stages of maturation could also be due to the decrease of cells. In the 
present study cell viability was evaluated by mitochondrial activity as 
measured by MTT assay. This mitochondrial integrity/activity may be 
interpreted as a measure of cell number, proliferation, viability, sur-
vival, or toxicity [56]. Expression of different NMDA receptors subunits 
at DIV3 compared to DIV5 might explain the different sensitivity of 
glutamate toxicity. In rat CGNs, Ceccon et al. [34] observed a similar 
lack of response to glutamate before DIV8, followed by increased 
sensitivity between DIV8 and DIV20. The POP mixture was toxic at 
either day, whilst PFOS only showed effect at DIV5. Recently Berntsen 
et al. reported that the same total POP mixture caused toxicity in rat 
CGNs with a significant impact on viability from 500x, and indicted an 
involvement of NMDA-R [38]. Similarly, Lee, Lee and Yang [57,58] 
showed that PFOS concentrations up to 30 μM did not cause any cyto-
toxicity in rat CGNs. Along the same line, Berntsen et al. [17] showed a 
lowest observed effect for PFOS at 20 μM in rat CGNs. It should be 
stressed that our PFOS concentration is comparable to reported con-
centrations of 26 μM in human serum levels in production workers [59]. 
Although the POP mixture and PFOS were capable of reducing MTT 
activity at DIV5, the reduction was more pronounced in presence of 
glutamate, suggesting an additive effect with the physiological 
stimulant. 
It is interesting to note that the complete POP mixture had negative 
effects on cellular health already in early stages of CGNs maturation 
(starting at DIV1), whereas PFOS was most potent in later stages (DIV5). 
Since the concentration used for PFOS was equivalent to the one present 
in the total POP mixture, it is obvious PFOS alone cannot mimic the 
effect of the full mixture. At present, we can only hypothesize about 
possible mechanisms. Other PFAS compounds present in the total 
mixture might contribute to a more potent cytotoxic effect. Indeed, all 
the six PFAS compounds have been found to induce cytotoxicity after 
24 h incubation in rat CGNs [17]. Moreover, the other classes of com-
pounds, PCBs, OCPs, and BFRs might contribute to the increased po-
tency of the total mixture. Indeed, both in vivo (for example in rat, mice) 
and in vitro (for example in primary CGNs and hippocampal neurons 
from rat and mice; PC12 and neuroblastoma cells) have shown that PCBs 
and BFRs could lead to disrupted calcium homeostasis, reduced gluta-
thione levels, formation of ROS, leading to neurotoxicity [60]. Alter-
natively, since maturation of the CGNs is paralleled with a shift in 
subunit composition of the NMDA-R [36], it might be that certain 
compounds in the total mixture might already have an affinity for more 
immature stages of the receptor, compared to PFOS. 
In CGNs the level of intracellular glutathione plays a major role in 
protecting cells against injury caused by ROS following excitotoxic in-
sults [34]. As such, a reduction in GSH level is involved in 
glutamate-induced cell death [35]. Direct depletion of mitochondrial 
and cytoplasmic GSH could result in increased level of ROS, decrease of 
the mitochondrial transmembrane potential and rapid loss of mito-
chondrial function [61]. Our observations indicate that glutamate 
exposure reduced the GSH level at either day, which is in agreement 
with observations by Sørvik and Paulsen [44]. When exposed to POP 
mixture or PFOS alone, GSH levels were reduced at either day. However, 
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the POP mixture aggravated the effect of glutamate-induced GSH 
reduction, suggesting an additive effect. No such additive effect was seen 
for PFOS in the presence of glutamate. For the POP mixture alone, or in 
combination with glutamate, the reductions in GSH paralleled the re-
ductions seen for MTT activity. This could indicate that the levels of GSH 
are setting the sensitivity of the CGNs to toxic insult. However, this was 
not the case for PFOS, suggesting it acts through a different mechanism 
for induction of toxicity. 
NMDA-R channels are highly Ca2+-permeable [36]. Their activation 
leads to a fast mitochondrial Ca2+ uptake, suggesting that Ca2+ influx 
through NMDA receptors has a privileged access to mitochondria, which 
could result in mitochondrial dysfunction [62,63]. In our hands the 
chicken CGNs responded to glutamate exposure with an increased Ca2+
influx, as previously described by Sørvik and Paulsen [44]. In contrast, 
neither the POP mixture, nor PFOS induced a Ca2+ influx on their own, 
indicating they do not reproduce the Ca2+ signaling induced by gluta-
mate. The absence of a PFOS-induced Ca2+ influx could be due to the 
low concentration. Indeed, Berntsen et al. [18] did not observe Ca2+
influx up to the concentration of 100 μM PFOS in rat CGNs. Interestingly, 
our observations showed that combinations of the POP mixture or the 
PFOS with glutamate significantly increased the effect of glutamate on 
Ca2+ influx. This indicates that exposure to environmental pollutants 
can combine with existing excitotoxic processes and aggravate adverse 
cellular outcomes. 
In a second step, we wanted to test whether known inhibitors of 
NMDA-R mediated Ca2+ influx could reverse the effects seen with 
combined glutamate and POP mixture or PFOS exposure. Glutamate- 
induced Ca2+ influx was reversed to control levels in presence of MK- 
801. The same trend was seen with CGP 39551, but non-significantly. 
This is in accordance with previous studies by Jacobs et al. [24,64] 
using MK-801. MK-801 is also very effective in reversing the Ca2+ influx 
induced by the combination of glutamate and the POP mixture or PFOS. 
In contrast, CGP 39551 proved far less effective in reversing this influx. 
It should be noted that MK-801 appeared to have very low 
voltage-dependency and slow unblocking kinetics to the ion channel 
[65], which may explain the higher protective effect of MK-801. CGP 
39551 on the other hand is a competitive antagonist and acts by binding 
to the glutamate binding site of the receptor [41]. 
MK-801 also restored the reduction in MTT activity for the POP ex-
posures in presence of glutamate. Thus, a calcium-dependent NMDA-R 
mediated toxicity seems at play here. Although CGP 39551 was less 
effective than MK-801 in blocking the Ca2+ influx, it also proved capable 
of reversing the reduction of MTT. Intriguingly, in absence of glutamate, 
the antagonists were also able to reverse cytotoxicity induced by either 
the POP mixture or PFOS. As no Ca2+ influx was observed under these 
conditions, this suggests a role for NMDA-R induced toxicity in a 
calcium-independent manner. Ca2+ flux-independent NMDA-R 
signaling has been reported previously. This could be due to confor-
mational changes of NMDA-R subunits that subsequently activates 
intracellular signaling cascades even in the absence of Ca2+ influx, and 
p38 MAP was found to mediate this effect [66]. 
In general, in our hands the effects of exposures for either POP 
mixture or PFOS became stronger with increased age of the CGNs cul-
tures in vitro. Berntsen, et al. [18] did also observe increased sensitivity 
of rat CGNs exposed to PFOS from DIV0 to DIV14. Also, neuroprotective 
effect of NMDA-R antagonists, including MK-801 was more pronounced 
at DIV14 as compared to DIV8. Recently, in another study Berntsen, 
et al. observed no toxicity in newly isolated immature rat CGNs when 
exposed to the same POP mixture from DIV0 to DIV8 as compared to 
cells exposed at DIV8 [38].This suggest that sensitivity of neurons 
changes with the maturation in culture. However, in our exposures there 
was a significant difference on DIV3 between effects of POP mixture and 
PFOS, whereas on DIV5 the effect of PFOS approached that of POP 
mixture in magnitude. 
We compared the endpoints/mechanism of toxicity of most of the 
compounds in the mixture from other in vitro studies with our POP 
mixture at 500x (fold human blood levels). As it can be seen from 
Supplementary Table 1, several of the single compounds have been 
linked with NMDA-R, ROS and Ca2+ homeostasis in neuronal cell 
models. However, when compared to other studies in vitro concentration 
of each individual compound in the mixture is still lower than concen-
trations reported. Although POP mixture at 500x looks high relative to 
Fig. 7. Overview of the cellular mechanisms involved 
in CGNs toxicity induced by POP mixture or PFOS 
alone, in absence or presence of glutamate. Reductions 
(bold down-arrows) or increases (bold up-arrows) of 
biological effects are shown. In the absence of gluta-
mate (left side of the figure), exposures with either POP 
mixture of PFOS alone, reduce intracellular glutathione 
(GSH) levels and induce CGNs toxicity by a Ca2+-in-
dependent mechanism. In the presence of glutamate 
(right side of the figure), exposures with either POP 
mixture or PFOS alone, aggravate glutamate-induced 
excitotoxicity by a Ca2+-dependent mechanism. 
Competitive (CGP 39551) and non-competitive (MK- 
801) NMDA-R antagonists can block the underlying 
mechanisms (indicated by blue lines with blunt end) 
and rescue CGNs cells from cytotoxicity (For interpre-
tation of the references to colour in this figure legend, 
the reader is referred to the web version of this article.).   
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measured blood concentrations, it should be stressed that the concen-
trations of the individual compounds are lower than those reported in in 
vitro studies. 
Our observations indicate PFOS is the major contributor from the 
PFAAs group, although future experiments are needed to exclude 
possible additive effects amongst the members of this group. Similarly, 
we did not investigate the other subgroups separately or combined with 
PFOS. However, a recent study from our group examined the effects of 
same total POP mixture as well as Cl, Br, and PFAAs group alone, and 
their combinations on in vitro exposed rat CGNs. They observed that the 
PFAAs mixture in combination with the Br and/or Cl mixtures exerted a 
stronger toxic effect than the PFAA mixture alone, indicating a degree of 
additivity between the sub-classes [38]. Further studies with the 
sub-mixtures of the different classes, combinations thereof, and the 
single compounds would be needed to explore the underlying 
mechanisms. 
Our study shows that exposure to POPs could interfere with NMDA 
glutamate receptors. Exposure to POPs have been associated with an 
increased prevalence of neurodevelopmental disorders including autism 
[1]. Changes in the expression of ionotropic glutamate receptors have 
been observed in autism for example, an upregulation of NMDA-R 
subunit protein levels has also been reported in the cerebellum of 
human postmortem samples [46]. In cerebellum the migration of 
granule neurons through layers of the cerebellar cortex is a key feature 
for the development of cerebellum and this neuronal migration is 
modulated by NMDA-R [23]. Perturbations of this process during 
development for example through exposure of pollutants could lead to 
developmental neurotoxicity and impaired brain development possibly 
via the involvement of NMDA receptors. 
5. Conclusion 
Primary chicken embryonal CGNs can be used as an in vitro model for 
evaluation of effects of persistent organic pollutants on developmental 
neurotoxicity. Our observations, schematized in Fig. 7, indicate that 
POPs affect different cellular and molecular endpoints in a complex 
fashion. The outcome depends on maturity of the CGNs. The exposures 
not only induce toxicity on their own, but also aggravate glutamate- 
induced excitotoxicity. The effect of the POP mixture cannot be 
explained by the action of PFOS only. With PFOS our observations in 
chicken embryo CGNs are similar to those previously reported in rat 
CGNs. Intracellular glutathione levels seem to set the levels of sensitivity 
to toxic insult. There seems to be two mechanisms for induction of 
toxicity, involving either a calcium-dependent or independent NMDA-R 
pathway. Importantly, antagonists of NMDA-R can inhibit the toxic ef-
fect of the exposures. 
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